IRIS
VETRANO, ERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.646
NA - Nord America 1.374
AS - Asia 1.256
SA - Sud America 161
Continente sconosciuto - Info sul continente non disponibili 69
AF - Africa 19
Totale 5.525
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 2.024
US - Stati Uniti d'America 1.329
SG - Singapore 379
IT - Italia 290
CN - Cina 262
VN - Vietnam 223
HK - Hong Kong 181
IE - Irlanda 132
BR - Brasile 128
KR - Corea 70
IN - India 64
DE - Germania 51
GB - Regno Unito 38
FR - Francia 24
JP - Giappone 19
CA - Canada 16
MX - Messico 15
PL - Polonia 11
NL - Olanda 10
AR - Argentina 8
AT - Austria 8
BD - Bangladesh 8
FI - Finlandia 8
SE - Svezia 7
TR - Turchia 7
CO - Colombia 6
EG - Egitto 6
ID - Indonesia 6
PK - Pakistan 6
LT - Lituania 5
PE - Perù 5
UA - Ucraina 5
VE - Venezuela 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CH - Svizzera 4
DK - Danimarca 4
PT - Portogallo 4
BO - Bolivia 3
CR - Costa Rica 3
EC - Ecuador 3
GR - Grecia 3
IL - Israele 3
PR - Porto Rico 3
RO - Romania 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
BE - Belgio 2
CZ - Repubblica Ceca 2
EE - Estonia 2
ES - Italia 2
ET - Etiopia 2
HN - Honduras 2
IR - Iran 2
KG - Kirghizistan 2
MA - Marocco 2
MO - Macao, regione amministrativa speciale della Cina 2
PY - Paraguay 2
RS - Serbia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
CW - ???statistics.table.value.countryCode.CW??? 1
GE - Georgia 1
HR - Croazia 1
IQ - Iraq 1
JM - Giamaica 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MU - Mauritius 1
MY - Malesia 1
NP - Nepal 1
PH - Filippine 1
SC - Seychelles 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
VG - Isole Vergini Britanniche 1
Totale 5.457
Salva come PNG Salva come JPEG
Città #
Moscow 731
San Jose 248
Singapore 195
Hong Kong 174
Ashburn 139
Dublin 126
Santa Clara 115
Council Bluffs 94
Chandler 81
Ho Chi Minh City 74
Hefei 70
Seoul 70
The Dalles 62
Naples 60
Hanoi 49
New York 46
Milan 35
Dallas 34
Bengaluru 30
Los Angeles 30
Beijing 28
Da Nang 18
Munich 18
São Paulo 13
Kochi 12
Atlanta 11
Cambridge 11
Orem 11
Princeton 11
Roxbury 11
Caserta 10
Falkenstein 10
Rome 9
Chicago 8
Haiphong 8
Memphis 8
Salerno 8
Chennai 7
Hải Dương 7
Liveri 7
Tokyo 7
Bremen 6
Denver 6
Florence 6
Mexico City 6
Miano 6
Stockholm 6
Warsaw 6
Amsterdam 5
Brooklyn 5
Can Tho 5
Des Moines 5
Frankfurt am Main 5
Hillsboro 5
Lahore 5
Phoenix 5
Toronto 5
Vienna 5
Baku 4
Belo Horizonte 4
Biên Hòa 4
Brasília 4
Damietta 4
Helsinki 4
Houston 4
Istanbul 4
Johannesburg 4
Lisbon 4
Norwalk 4
Paris 4
Seattle 4
Yên Bái 4
Zurich 4
Andover 3
Bari 3
Bexley 3
Boston 3
Boydton 3
Cagliari 3
Calgary 3
Chengdu 3
Dhaka 3
Guarulhos 3
Ha Long 3
Honolulu 3
La Paz 3
Lappeenranta 3
Lima 3
Manaus 3
Manchester 3
Mumbai 3
Nha Trang 3
Nuremberg 3
Queens 3
Rio de Janeiro 3
San Francisco 3
San José 3
Shenzhen 3
Terzigno 3
The Bronx 3
Totale 2.929
Salva come PNG Salva come JPEG
Nome #
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 209
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 196
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 168
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 167
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 167
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 162
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 162
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 161
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects? 155
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 154
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 145
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 144
HCC and molecular targeting therapies: Back to the future 142
Pathophysiology, Functional Assessment and Prognostic Implications of Nutritional Disorders in Systemic Amyloidosis 141
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 141
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 141
Cardiovascular benefits from gliflozins: Effects on endothelial function 141
Advances in the Insulin-Heart Axis: Current Therapies and Future Directions 140
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 136
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 136
EFFICACY OF COVID-19 VACCINATION IN PATIENTS WITH IMMUNE SYSTEM DISORDERS AND CANCER 134
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence 134
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 131
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 129
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 129
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 129
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 124
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 122
Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function 122
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 119
Editorial - Direct-acting antivirals therapy in HCV patients with HCC: lights and shadow 115
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications 112
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence 107
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 102
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms 100
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms 98
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 97
Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice 95
Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN Study 89
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 86
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 80
Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects 63
Totale 5.525
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.862
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.862
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202293 0 0 0 17 20 6 4 2 3 2 11 28
2022/2023292 17 15 8 17 35 16 4 22 133 8 5 12
2023/2024234 31 11 6 18 47 36 4 9 5 15 22 30
2024/2025712 6 13 3 11 103 76 102 68 133 65 59 73
2025/20263.686 193 234 199 115 317 1.859 292 185 122 72 55 43
2026/2027493 25 42 214 212 0 0 0 0 0 0 0 0
Totale 5.525